Feng Liu

Feng Liu is an accomplished professional in the field of oncology, currently serving as the Director and Translational Oncology Lead at Pfizer since September 2017. In this role, Feng Liu develops robust translational oncology strategies to facilitate clinical decision-making and patient stratification for early drug development projects. Previously, at Sanofi Oncology, Feng Liu held the positions of Lead Research Investigator and Senior Research Investigator, focusing on translational medicine and bioinformatics, respectively. Early career experience includes working as an Associate Scientist at Hoechst Marion Roussel and conducting postdoctoral research at Washington University School of Medicine. Feng Liu’s educational background includes a Master of Business Administration from Rutgers University, a Doctor of Philosophy in Cell/Cellular and Molecular Biology from the University of Vermont, and a degree from Peking Union Medical College.